While flu and COVID cases are now on the rise, RSV infections may soon peak and level off, U.S. health officials report, says an article published on US news website.
COVID-19 Impact
Amid a continuous surge in COVID-19 cases, leading to about 15,000 hospitalizations and 1,000 deaths weekly, Dr. Mandy Cohen from the U.S. Centers for Disease Control and Prevention provides insights to the House Energy and Commerce Subcommittee on Oversight and Investigations.
Flu Cases Rising
Recent data from the CDC reveals an increase in flu-like illnesses, with 11 states, predominantly in the South and Southwest, reporting high levels. This marks a rise from the initial count of seven states in early November.
RSV Surge
RSV infections have spiked in various regions, causing strain on hospital emergency departments, notably in Georgia. Dr. Cohen anticipates reaching the peak of the RSV season within the next week. Fortunately, this winter sees the approval of vaccines and preventive drugs against RSV for the first time.
Pneumonia Cases And China’s Situation
Addressing concerns about pneumonia cases among children in Massachusetts and Ohio, Dr. Cohen emphasizes no evidence of unusual causes. Meanwhile, China experiences a surge in respiratory illnesses, largely attributed to the flu and conventional factors.
Key Points
- COVID-19 remains a significant contributor to hospitalizations and deaths.
- Flu cases surge in 11 states, mainly in the South and Southwest.
- RSV infections strain hospital resources, especially in Georgia.
- Winter welcomes approved vaccines and preventive drugs for RSV.
- Pneumonia cases in Massachusetts and Ohio lack evidence of unusual causes.
- China’s respiratory illness surge attributed to the flu and typical factors.
Did you subscribe to our daily newsletter?
It’s Free! Click here to Subscribe!
Source: US news
